Summary

In this Senior Director level role, you will help identify, assess, and prioritize United States evidence needs for the relevant therapeutic area. You will play a key role in ensuring that local stakeholder, asset, and healthcare system priorities inform global evidence plans and investment decisions. As part of the Global Evidence Generation organization, you will partner with scientific, medical, research, and cross-functional teams to develop and deliver rigorous evidence strategies. Your work will contribute to interventional studies, real-world evidence, observational research, database studies, and research collaborations that support patient access and healthcare decision-making. You will also help strengthen the quality, speed, efficiency, and impact of evidence planning and delivery through innovation, automation, digital tools, advanced analytics, and artificial intelligence-enabled approaches.

Job description

About the Role

In this Senior Director level role, you will help identify, assess, and prioritize United States evidence needs for the relevant therapeutic area. You will play a key role in ensuring that local stakeholder, asset, and healthcare system priorities inform global evidence plans and investment decisions. As part of the Global Evidence Generation organization, you will partner with scientific, medical, research, and cross-functional teams to develop and deliver rigorous evidence strategies. Your work will contribute to interventional studies, real-world evidence, observational research, database studies, and research collaborations that support patient access and healthcare decision-making. You will also help strengthen the quality, speed, efficiency, and impact of evidence planning and delivery through innovation, automation, digital tools, advanced analytics, and artificial intelligence-enabled approaches.

How You Will Contribute

Identify and prioritize evidence needs for United States stakeholders, assets, patients, payers, healthcare systems, regulators, and prescribers.
Shape evidence generation plans by ensuring priority United States needs inform global strategies, studies, investments, and governance decisions.
Guide study design decisions by evaluating scientific rigor, methodological feasibility, data sources, endpoints, and regulatory and payer relevance.
Oversee priority studies by monitoring contracts, timelines, budgets, quality milestones, external partnerships, and delivery risks.
Direct portfolio governance covering scenario planning, investment trade-offs, resource allocation, decision-making, and risk escalation.
Build strategic research relationships with healthcare systems, investigators, patient organizations, academic institutions, data partners, and scientific groups.
Advance digital and analytical capabilities to improve evidence planning, operational efficiency, scalability, quality, and impact.

Qualifications

Advanced degree in a scientific, clinical, epidemiological, quantitative, health economics, or health outcomes discipline.
At least 11 years of relevant experience with a doctoral degree or 13 years with a master's degree.
Relevant experience in real-world evidence, epidemiology, health outcomes research, medical evidence generation, or a related environment.
Demonstrated expertise in evidence gap assessment, study design, and scientific leadership within a stated therapeutic area.
Strong understanding of United States healthcare systems, payer requirements, regulatory evidence needs, reimbursement decisions, and managed care.
Ability to translate medical and healthcare questions into clear evidence gaps and scientifically sound, feasible research plans.
Strong scientific judgment when evaluating study designs, data sources, analyses, endpoints, patient populations, and scientific outputs.
Professional fluency in English with strong stakeholder influence, matrix leadership, communication, facilitation, presentation, digital, and data science skills.

Requirements

Advanced degree in a scientific, clinical, epidemiological, quantitative, health economics, or health outcomes discipline
At least 11 years of relevant experience with a doctoral degree or 13 years with a master's degree
Relevant experience in real-world evidence, epidemiology, health outcomes research, medical evidence generation, or a related environment
Demonstrated expertise in evidence gap assessment, study design, and scientific leadership within a stated therapeutic area
Strong understanding of United States healthcare systems, payer requirements, regulatory evidence needs, reimbursement decisions, and managed care
Ability to translate medical and healthcare questions into clear evidence gaps and scientifically sound, feasible research plans
Strong scientific judgment when evaluating study designs, data sources, analyses, endpoints, patient populations, and scientific outputs
Professional fluency in English with strong stakeholder influence, matrix leadership, communication, facilitation, presentation, digital, and data science skills

Benefits

401(k) Matching
Medical, Dental & Vision
Paid Time Off

Company overview

Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company founded in 1781 and incorporated in 1925. As one of the world's top 20 largest pharmaceutical companies by revenue and the third largest in Asia, Takeda specializes in developing and commercializing innovative medicines across several therapeutic areas including oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies, and vaccines. With approximately 49,095 employees globally, the company operates research and development centers, manufacturing facilities, and commercial operations across 39 U.S. states and numerous countries worldwide. Takeda maintains dual headquarters in Tokyo and Osaka, Japan, with significant operations in Cambridge, Massachusetts, where it serves as the largest life sciences employer in the state. The company's patient-focused approach is guided by its Takeda-ism values of Integrity, Fairness, Honesty, and Perseverance, emphasizing a commitment to delivering life-transforming treatments while advancing sustainable healthcare solutions. Takeda's extensive portfolio includes both innovative biologics and small molecule drugs, supported by strategic acquisitions and partnerships that have expanded its capabilities in areas such as immuno-oncology and rare disease treatments.